CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 31 filers reported holding CASI PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,000 | -84.4% | 2,262 | -78.6% | 0.00% | – |
| Q4 2020 | $32,000 | +540.0% | 10,588 | +243.8% | 0.00% | – |
| Q3 2020 | $5,000 | -50.0% | 3,080 | -28.4% | 0.00% | – |
| Q2 2020 | $10,000 | -50.0% | 4,301 | -33.9% | 0.00% | – |
| Q4 2019 | $20,000 | +33.3% | 6,507 | +47.1% | 0.00% | – |
| Q3 2019 | $15,000 | +7.1% | 4,423 | +3.6% | 0.00% | – |
| Q2 2019 | $14,000 | +366.7% | 4,271 | +506.7% | 0.00% | – |
| Q4 2018 | $3,000 | +50.0% | 704 | +104.7% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 344 | -2.8% | 0.00% | – |
| Q2 2018 | $3,000 | – | 354 | +293.3% | 0.00% | – |
| Q2 2016 | $0 | – | 90 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 90 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 90 | +150.0% | 0.00% | – |
| Q1 2015 | $0 | – | 36 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 36 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields & Co., LLC | 896,137 | $4,185,000 | 2.27% |
| Wellington Shields Capital Management, LLC | 888,333 | $4,149,000 | 0.67% |
| Manatuck Hill Partners, LLC | 15,090 | $70,000 | 0.03% |
| IHT Wealth Management, LLC | 10,725 | $50,000 | 0.01% |
| Perceptive Advisors | 43,682 | $204,000 | 0.01% |
| ALPS ADVISORS INC | 153,234 | $716,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 78,742 | $368,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 5,863 | $28,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,974 | $28,000 | 0.00% |
| METROPOLITAN LIFE INSURANCE CO/NY | 18,585 | $86,792 | 0.00% |